APA (7th ed.) Citation

G, D. L., A, V., L, S., R, B., F, G., F, P., . . . C, B. (2026). Development and Validation of the PREVES-HOR Questionnaire: A Patient-Reported Measure of Hormone Therapy-Related Quality of Life in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy. Oncology, 104(6), 639. https://doi.org/10.1159/000548317

Chicago Style (17th ed.) Citation

G, Di Lorenzo, et al. "Development and Validation of the PREVES-HOR Questionnaire: A Patient-Reported Measure of Hormone Therapy-Related Quality of Life in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy." Oncology 104, no. 6 (2026): 639. https://doi.org/10.1159/000548317.

MLA (9th ed.) Citation

G, Di Lorenzo, et al. "Development and Validation of the PREVES-HOR Questionnaire: A Patient-Reported Measure of Hormone Therapy-Related Quality of Life in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy." Oncology, vol. 104, no. 6, 2026, p. 639, https://doi.org/10.1159/000548317.